GH
Georgina El Hajjar
Credentials:
History
- 2022–2026
Medical School
Research
Immunophenotypic changes following menin inhibition in acute myeloid leukemia
Leukemia · 2026 · 4 citations
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Journal of Clinical Oncology · 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia
Cancer · 2026
4 papers
4 papers
3 papers · 3 as a resident
3 papers
3 papers
3 papers
3 papers
3 papers
